Stockreport
Amgen (AMGN) Stock Up Since Jim Cramer Said “You Could Do a Lot Worse Than Amgen” [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Amgen Inc. (NASDAQ:AMGN) is one of the largest drug companies in the world. The firm is currently developing the weight loss drug MariTide. Its shares are up by 11.9% over the past year and are up by 24% since Cramer discussed the firm in June 2025 on Mad Money. They closed 7.5% higher on November 2025 after Amgen Inc. (NASDAQ:AMGN) released its earnings report for the fiscal third quarter. The results saw the firm post $9.6 billion in revenue and $5.64 in per share profit. Analysts, on the other hand, had expected Amgen Inc. (NASDAQ:AMGN) to post $8.98 billion in revenue and $5.04 in profit per share. 2026 has also been a good year for the shares as they are up by 6.5%. One notable movement occurred on February 4th when the stock closed 8% higher. On the 3rd, Amgen Inc. (NASDAQ:AMGN) had reported its fourth quarter earnings, which saw the firm post $9.9 billion in revenue and $5.29 in adjusted earnings per share to beat analyst estimates. Cramer was cautiously optimistic about the f
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now? [Yahoo! Finance][Yahoo! Finance]
- Zai Lab gains after clinical trial pact with Amgen [Seeking Alpha][Seeking Alpha]
- Bristol Myers Squibb adding 3 medications on TrumpRx [FOX Business Network][FOX Business Network]
- Teva gains approval of biosimilar of Amgen's Prolia [Seeking Alpha][Seeking Alpha]
- REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS [Yahoo! Finance][Yahoo! Finance]
- More
AMGN
SEC Filings
SEC Filings
- 3/31/26 - Form ARS
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 4
- AMGN's page on the SEC website
- More